Found: 115
Select item for more details and to access through your institution.
Insulin therapy and hypoglycaemia: the size of the problem.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. S2, p. S32, doi. 10.1002/dmrr.514
- By:
- Publication type:
- Article
Insulin: evolution of insulin formulations and their application in clinical practice over 100 years.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 9, p. 1129, doi. 10.1007/s00592-022-01938-4
- By:
- Publication type:
- Article
Sulphonylureas and pregnancy.
- Published in:
- European Journal of Endocrinology, 1998, v. 138, n. 6, p. 615, doi. 10.1530/eje.0.1380615
- By:
- Publication type:
- Article
Subnormal pancreatic polypeptide and epinephrine responses to insulin-induced hypoglycemia identify patients with insulin-dependent diabetes mellitus predisposed to develop overt autonomic neuropathy.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Plasma proteomic signatures of a direct measure of insulin sensitivity in two population cohorts.
- Published in:
- Diabetologia, 2023, v. 66, n. 9, p. 1643, doi. 10.1007/s00125-023-05946-z
- By:
- Publication type:
- Article
Treatment and Prevention of Hypoglycemia and its Unawareness in Type 1 Diabetes Mellitus.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2003, v. 4, n. 4, p. 335
- By:
- Publication type:
- Article
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 503, doi. 10.1111/dom.15336
- By:
- Publication type:
- Article
A comparison of the effectiveness and safety of insulin glargine 300 U/ml versus 100 U/ml in children and adolescents with newly diagnosed type 1 diabetes: A retrospective, observational, short‐term study.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2474, doi. 10.1111/dom.14839
- By:
- Publication type:
- Article
C‐peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1912, doi. 10.1111/dom.14785
- By:
- Publication type:
- Article
Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 327, doi. 10.1111/dom.14560
- By:
- Publication type:
- Article
Insulin Centennial: Milestones influencing the development of insulin preparations since 1922.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, p. 27, doi. 10.1111/dom.14587
- By:
- Publication type:
- Article
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1588, doi. 10.1111/dom.14372
- By:
- Publication type:
- Article
Equipotency of insulin glargine 300 and 100 U/mL with intravenous dosing but differential bioavailability with subcutaneous dosing in dogs.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 166, doi. 10.1111/dom.14212
- By:
- Publication type:
- Article
Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1880, doi. 10.1111/dom.14109
- By:
- Publication type:
- Article
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1664, doi. 10.1111/dom.14065
- By:
- Publication type:
- Article
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1369, doi. 10.1111/dom.14043
- By:
- Publication type:
- Article
The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 743, doi. 10.1111/dom.13963
- By:
- Publication type:
- Article
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 315, doi. 10.1111/dom.13897
- By:
- Publication type:
- Article
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0%.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 321, doi. 10.1111/dom.13607
- By:
- Publication type:
- Article
A post‐hoc pooled analysis to evaluate the risk of hypoglycaemia with insulin glargine 300 U/mL (Gla‐300) versus 100 U/mL (Gla‐100) over wider nocturnal windows in individuals with type 2 diabetes on a basal‐only insulin regimen.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 402, doi. 10.1111/dom.13515
- By:
- Publication type:
- Article
Hypoglycaemia risk in the first 8 weeks of titration with insulin glargine 100 U/mL in previously insulin‐naive individuals with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2894, doi. 10.1111/dom.13450
- By:
- Publication type:
- Article
Glycaemic control, hypoglycaemia, and weight change with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Japanese adults with type 2 diabetes: A 12‐month comparison by concomitant sulphonylurea and/or glinide use.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2541, doi. 10.1111/dom.13414
- By:
- Publication type:
- Article
Glycaemic control and hypoglycaemia during 12 months of randomized treatment with insulin glargine 300 U/mL versus glargine 100 U/mL in people with type 1 diabetes ( EDITION 4).
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 1, p. 121, doi. 10.1111/dom.13048
- By:
- Publication type:
- Article
Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ mL added to oral antidiabetes agents in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1546, doi. 10.1111/dom.12966
- By:
- Publication type:
- Article
Short-Term Effects of the Long-Acting Insulin Analog Detemir and Human Insulin on Plasma Levels of Insulin-Like Growth Factor-I and Its Binding Proteins in Humans.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2009, v. 94, n. 8, p. 3017, doi. 10.1210/jc.2008-2838
- By:
- Publication type:
- Article
Autoantibody Recognition of COOH-Terminal Epitopes of GAD65 Marks the Risk for Insulin Requirement in Adult-Onset Diabetes Mellitus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 1, p. 309, doi. 10.1210/jcem.85.1.6301
- By:
- Publication type:
- Article
Gender Differences in Basal Protein Kinetics in Young Adults.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 12, p. 4363, doi. 10.1210/jcem.83.12.5330
- By:
- Publication type:
- Article
Comparison of Glucose Counterregulation During Short-Term and Prolonged Hypoglycemia in Normal Humans.
- Published in:
- Diabetes, 1986, v. 35, n. 5, p. 563, doi. 10.2337/diabetes.35.5.563
- By:
- Publication type:
- Article
Demonstration of a dawn phenomenon in normal human volunteers.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type I diabetes mellitus.
- Published in:
- 1984
- By:
- Publication type:
- journal article
The Adrenergic Contribution to Glucose Counterregulation in Type I Diabetes Mellitus.
- Published in:
- Diabetes, 1983, v. 32, n. 10, p. 887, doi. 10.2337/diabetes.32.10.887
- By:
- Publication type:
- Article
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
- Published in:
- 1982
- By:
- Publication type:
- journal article
The importance of determining irreversibly glycosylated hemoglobin in diabetics.
- Published in:
- 1981
- By:
- Publication type:
- journal article
HbA1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Serum insulin and C-peptide concentration and breast cancer: a meta-analysis.
- Published in:
- Cancer Causes & Control, 2013, v. 24, n. 5, p. 873, doi. 10.1007/s10552-013-0164-6
- By:
- Publication type:
- Article
Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Administration of Neutral Protamine Hagedorn Insulin at Bedtime versus with Dinner in Type 1 Diabetes Mellitus To Avoid Nocturnal Hypoglycemia and Improve Control.
- Published in:
- Annals of Internal Medicine, 2002, v. 136, n. 7, p. 504, doi. 10.7326/0003-4819-136-7-200204020-00007
- By:
- Publication type:
- Article
Counterregulatory Mechanisms to Insulin-Induced Hypoglycemia in Humans: Relevance to the Problem of Intensive Treatment of IDDM.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 1998, v. 11, p. 103, doi. 10.1515/jpem.1998.11.s1.103
- By:
- Publication type:
- Article
Foreword.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 1998, v. 11, p. 97, doi. 10.1515/jpem.1998.11.s1.97
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 5, p. 1261, doi. 10.2337/dc06-2208
- By:
- Publication type:
- Article
The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Glucose Variability and Complications.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Contribution of Postprandial Versus Interprandial Blood Glucose to HbA[sub 1c] in Type 1 Diabetes on Physiologic Intensive Therapy With Lispro Insulin at Mealtime.
- Published in:
- Diabetes Care, 1999, v. 22, n. 5, p. 795, doi. 10.2337/diacare.22.5.795
- By:
- Publication type:
- Article
Long-Term Intensive Treatment of Type 1 Diabetes With the Short-Acting Insulin Analog Lispro in Variable Combination With NPH Insulin at Mealtime.
- Published in:
- Diabetes Care, 1999, v. 22, n. 3, p. 468, doi. 10.2337/diacare.22.3.468
- By:
- Publication type:
- Article
Strategies Toward Improved Control During Insulin Lispro Therapy in IDDM.
- Published in:
- Diabetes Care, 1997, v. 20, n. 8, p. 1287, doi. 10.2337/diacare.20.8.1287
- By:
- Publication type:
- Article
Mixing insulin lispro and ultralente insulin.
- Published in:
- 1997
- By:
- Publication type:
- commentary
Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM.
- Published in:
- Diabetes Care, 1996, v. 19, n. 9, p. 945, doi. 10.2337/diacare.19.9.945
- By:
- Publication type:
- Article
Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function.
- Published in:
- Diabetes Care, 1995, v. 18, n. 11, p. 1452
- By:
- Publication type:
- Article